Shares of Siemens Healthineers AG (ETR:SHL - Get Free Report) traded down 3.8% during trading on Tuesday . The company traded as low as €49.38 ($53.67) and last traded at €49.38 ($53.67). 608,024 shares were traded during trading, The stock had previously closed at €51.32 ($55.78).
Siemens Healthineers Stock Down 3.8 %
The company has a quick ratio of 0.71, a current ratio of 1.27 and a debt-to-equity ratio of 92.22. The stock has a market capitalization of $55.31 billion, a price-to-earnings ratio of 29.75, a price-to-earnings-growth ratio of 1.16 and a beta of 0.70. The stock has a 50 day moving average price of €51.24 and a 200 day moving average price of €52.32.
Siemens Healthineers Company Profile
(
Get Free Report)
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Siemens Healthineers, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Siemens Healthineers wasn't on the list.
While Siemens Healthineers currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
